Peter Zhang
Acadia Pharmaceuticals (United States)(US)University of British Columbia(CA)University of Victoria(CA)Dana-Farber Cancer Institute(US)Dana-Farber/Harvard Cancer Center(US)Carnegie Mellon University(US)
Publications by Year
Research Areas
Treatment of Major Depression, Capital Investment and Risk Analysis, Schizophrenia research and treatment, RNA Research and Splicing, Cancer-related molecular mechanisms research
Most-Cited Works
- → Transcribed enhancers lead waves of coordinated transcription in transitioning mammalian cells(2015)606 cited
- → An integrated expression atlas of miRNAs and their promoters in human and mouse(2017)597 cited
- → MiR-21 Indicates Poor Prognosis in Tongue Squamous Cell Carcinomas as an Apoptosis Inhibitor(2009)430 cited
- → Microtubule-associated protein tau: A marker of paclitaxel sensitivity in breast cancer(2005)408 cited
- → Meta-analysis of results from eight randomized, placebo-controlled trials on the effect of cilostazol on patients with intermittent claudication(2002)309 cited
- Epidermal growth factor receptor-targeted therapy with C225 and cisplatin in patients with head and neck cancer.(2001)
- →